New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 12, 2014
08:04 EDTARNAArena Pharmaceuticals to receive $500K milestone paument from Eisai
Arena Pharmaceuticals will receive a milestone payment of $500K from Eisai Laboratorios Ltda., a subsidiary of Eisai Inc., related to the filing of a marketing authorization for Belviq as a treatment for chronic weight management with the Brazilian Health Surveillance Agency.
News For ARNA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 8, 2014
06:47 EDTARNAArena says Teva files marketing authorization of Belviq in Israel
Arena Pharmaceuticals (ARNA) disclosed late Friday that Teva Pharmaceutical's (TEVA) local Israeli subsidiary, Abic Marketing Limited, has filed for marketing authorization of Belviq in Israel. In connection with the filing, Arena will receive a milestone payment of $250K.
06:45 EDTARNAArena says Eisai withdraws Belviq application in Canada
Subscribe for More Information
06:44 EDTARNAArena Pharmaceuticals says 'small number' of Belviq labels incomplete
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use